Med. praxi. 2012;9(5):233-237

Thyroid disease in pregnancy

MUDr.Jan Jiskra, Ph.D.
3. Interní klinika 1. LF UK a VFN Praha

Thyroid disease affects a significant proportion of women of childbearing age and, when untreated, it may cause infertility, complications

in pregnancy, and fetal developmental defects. Laboratory standards for thyroid parameters are different from those for the general

population. The most reliable and best standardized parameter in pregnancy is serum thyroid-stimulating hormone (TSH) which should

be kept in the range of 0.1–2.5 mIU/L in the first trimester. Hypothyroidism in pregnancy must always be treated, with replacement

therapy being initiated with a full dose and the TSH level maintained up to 2.5 mIU/L. Propylthiouracyl is used to treat hyperthyroidism

in pregnancy in the first trimester and methimazole is used since the second trimester and during breastfeeding. There is not sufficient

evidence for systemic treatment of autoimmune thyroid disease without thyroid dysfunction in pregnancy and an individual approach

is taken. In all pregnant women at risk or those planning to become pregnant, screening for TSH and anti-thyroid peroxidase antibodies

should be done in early pregnancy or before conception.

peroxidase antibodies.

Keywords: hypothyroidism, subclinical hypothyroidism, hyperthyroidism, pregnancy, thyroid-stimulating hormone, anti-thyroid

Published: May 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jiskra J. Thyroid disease in pregnancy. Med. praxi. 2012;9(5):233-237.
Download citation

References

  1. Glinoer D, Fernandez-Soto ML, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussions. J Clin Endocrinol Metab, 1991; 71: 421-427. Go to original source... Go to PubMed...
  2. Pop VJ, de Vries E, van Baar AL, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endorinol Metab, 1995; 80: 3561-3566. Go to original source... Go to PubMed...
  3. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychlogical development of the child. N Engl J Med, 1999; 341: 549-555. Go to original source... Go to PubMed...
  4. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011, 9; 342: d2616. Go to original source... Go to PubMed...
  5. Jiskra J, Bartáková J, Holinka Š, Límanová Z, Springer D, Fait T, Antošová M, Telička Z, Potluková E. Low concordance between positive antibodies to thyroperoxidase and thyroid ultrasound autoimmune pattern in pregnant women. Endocr J. 2011, 29; 58(10): 849-859. Go to original source... Go to PubMed...
  6. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W. American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21(10): 1081-1125. Go to original source... Go to PubMed...
  7. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587-2591. Go to original source... Go to PubMed...
  8. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005; 20: 1529-1533. Go to original source... Go to PubMed...
  9. Abalovich M, Nobuyuki A, Barbour LA, et al. Clinical Practice Guideline. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2007; 92(Suppl 8): S1-47. Go to original source... Go to PubMed...
  10. Lazarus JH. Postpartum thyroid disease. In: Lazarus JH, Pirags V, Butz S. The thyroid and reproduction. Merck European Thyroid Symposium, Georg Tieme Verlag, Stuttgart, 2008: 105-113. Go to original source...
  11. Ghassabian A, Bongers-Schokking JJ, de Rijke YB, van Mil N, Jaddoe VW, de Muinck Keizer-Schrama SM, Hooijkaas H, Hofman A, Visser W, Roman GC, Visser TJ, Verhulst FC, Tiemeier H. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid. 2012; 22(2): 178-186. Go to original source... Go to PubMed...
  12. McTiernan AM, Weiss NS, Daling JR 1984 Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120: 423-435. Go to original source... Go to PubMed...
  13. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, Chiusano E, John R, Guaraldo V, George LM, Perona M, Dall'Amico D, Parkes AB, Joomun M, Wald NJ. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012, 9; 366(6): 493-501. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.